Literature DB >> 200172

Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.

R J Klein, A E Friedman-Kien.   

Abstract

Adenine arabinoside (Ara-A) and Ara-A monosphosphate (Ara-AMP) ointments were able to prevent the fatal outcome of herpes simplex virus (HSV)-induced skin infection of the lumbosacral area in hairless mice. Ara-A and Ara-AMP had no irritating effect on the skin, but in a number of animals a protracted healing time of the skin lesions after the treatment was observed. The compounds conferred only a partial protection against the establishment of latent HSV infection in the spinal root ganglia of the treated animals. The immune response, as judged from levels of HSV-specific neutralizing serum antibody titers, was not impaired by the antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200172      PMCID: PMC429979          DOI: 10.1128/AAC.12.5.577

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Isolation of herpes simplex virus clones and drug resistant mutants in microcultures.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.

Authors:  C R Wohlenberg; M A Walz; A L Notkins
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

3.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

5.  Effects of adenine arabinoside on cellular immune mechanisms in humans.

Authors:  R W Steele; I A Chapa; M M Vincent; S A Hensen; R E Keeney
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

6.  Adenine arabinoside effect on experimental idoxuridine-resistant herpes simplex infection.

Authors:  A B Nesburn; C Robinson; R Dickinson
Journal:  Invest Ophthalmol       Date:  1974-04

7.  Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalis.

Authors:  E L Goodman; J P Luby; M T Johnson
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

8.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Cellular immune responses to herpesviruses during treatment with adenine arabinoside.

Authors:  R W Steele; R E Keeney; J Brown; E J Young
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

  9 in total
  9 in total

1.  Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.

Authors:  R J Klein; A E Friedman-Kien; P B Yellin
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 2.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

Authors:  E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

5.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

6.  Effects of topical applications of phosphonoacetate on colonization of mouse trigeminal ganglia with herpes simplex virus type 1.

Authors:  R J Klein; A E Friedman-Kien; L Kaley; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

7.  Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.

Authors:  P H Lee; M H Su; E R Kern; W I Higuchi
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 9.  Rapid and accurate viral diagnosis.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.